Furthermore, the enhanced expression of NDRG2 remarkably inhibited the suppression of cell proliferation and the protein degradation of AKT and NEMO with the treatment of PRMT5 inhibitors in tumour cells. This evidence concerns the gene PRMT5 and neoplasm.